Evidence map›Paper›PMID 32024040›Full record

ArticleMarine drugs2020

Novel

Mónica Estupiñán, Igor Hernández, Eduardo Saitua, M Elisabete Bilbao, Iñaki Mendibil, Jorge Ferrer, Laura Alonso-Sáez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Detection ofMicroorganisms · 2022
    Article
  4. Review
  5. Review
  6. Microbial Profiles of Retail Pacific Oysters (Frontiers in microbiology · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mónica EstupiñánAZTI, Marine Research Division, Txatxarramendi Irla s/n, 48395 Sukarrieta, Spain.
Igor HernándezAZTI, Food Research Division, Astondo Bidea, Building 609, 48160 Derio, Spain.
Eduardo SaituaAZTI, Food Research Division, Astondo Bidea, Building 609, 48160 Derio, Spain.
M Elisabete BilbaoAZTI, Marine Research Division, Txatxarramendi Irla s/n, 48395 Sukarrieta, Spain.
Iñaki MendibilAZTI, Marine Research Division, Txatxarramendi Irla s/n, 48395 Sukarrieta, Spain.
Jorge FerrerAZTI, Food Research Division, Astondo Bidea, Building 609, 48160 Derio, Spain.
Laura Alonso-SáezAZTI, Marine Research Division, Txatxarramendi Irla s/n, 48395 Sukarrieta, Spain.
Instituto de Investigacións Mariñas · ESAZTI · ES

Funding

Eusko Jaurlaritza KK-2016/00057- 'MAROMEGA: New alternatives for the omega-3 fatty acid production from marine resources
6 · The paper itself

Abstract

Omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs), such as eicosapentaenoic acid (EPA) (20:5n-3) and docosahexaenoic acid (DHA) (22:6n-3), are considered essential for human health. Microorganisms are the primary producers of omega-3 fatty acids in marine ecosystems, representing a sustainable source of these lipids, as an alternative to the fish industry. Some marine bacteria can produce LC-PUFAs de novo via the Polyunsaturated Fatty Acid (

Indexed as

Docosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3GenotypeMultigene FamilyPhenotypeRNA, Ribosomal, 16SSeawaterSpainVibrioDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3RNA, Ribosomal, 16Seicosapentaenoic acid (EPA)marine gamma-Proteobacteriaomega-3 fatty acidpolyketide synthase (PKS)polyunsaturated fatty acid synthase PfaVibrio sp.

Identifiers

PMID32024040
PMCPMC7074563
OpenAlexW3003638944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.